Artículos seleccionados

El experto opina

Artículos seleccionados

Artículo seleccionado

Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research

Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research. © World Health Organization 2015. Regional Office for Europe
http://apps.who.int/medicinedocs/documents/s21793en/s21793en.pdf

Comentado por:

Albert Figueras
Profesor del Departamento de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona

Artículo seleccionado

Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries

Gammie T, Lu CY, Babar ZU-D. Access to Orphan Drugs: A Comprehensive Review of Legislations, Regulations and Policies in 35 Countries. PLoS ONE. 2015; 10(10): e0140002.
Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599885/

Comentado por:

Jorge Mestre-Ferrandiz
Director de Consultoría. Office of Health Economics. Londres.

Artículos seleccionados

Principles for consistent value assessment and sustainable funding of orphan drugs in Europe

Estimating the budget impact of orphan medicines in Europe: 2010 – 2020

Gutierrez L, Patris J, Hutchings A, Cowell W. Principles for consistent value assessment and sustainable funding of orphan drugs in Europe. Orphanet J Rare Dis 2015, 10:53. doi10.1186/s13023-015-0269-y. Disponible en: http://www.ojrd.com/content/pdf/s13023-015-0269-y.pdf 

Schey C, Milanova T, Hutchings A. Estimating the budget impact of orphan medicines in Europe: 2010 – 2020. Orphanet J Rare Dis 2011, 6:62. Disponible en: http://www.ojrd.com/content/pdf/1750-1172-6-62.pdf

Comentados por:

Carlos Campillo-Artero
Servicio de Salud de les Illes Balears, Centre de Recerca en Economía i Salut, Universitat Pompeu Fabra

Dr. Julio Martínez
Coordinador Clínico. Jefe del Servicio de Farmacia. Hospital Universitario Vall d'Hebron. Barcelona